Susmed (TSE:4263) Other Current Liabilities: 円55.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4263 Susmed Inc TSE:4263
55 GF Score
Price 円423.00
GF Value 円904.00
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Susmed Other Current Liabilities?

Susmed TSE:4263 -4.08% 55 Other Current Liabilities is 円55.3 Mil as of Mar. 2026. GuruFocus rates TSE:4263 with a GF Score™ of 55/100 and a GF Value™ of 円904.00 (Possible Value Trap). The stock has 4 warning signs investors should review.

Susmed's other current liabilities for the quarter that ended in Mar. 2026 was 円55.3 Mil.

Susmed's quarterly other current liabilities declined from Sep. 2025 (円50.2 Mil) to Dec. 2025 (円49.7 Mil) but then increased from Dec. 2025 (円49.7 Mil) to Mar. 2026 (円55.3 Mil).

Susmed's annual other current liabilities declined from Jun. 2024 (円254.3 Mil) to Jun. 2025 (円54.3 Mil) but then increased from Jun. 2025 (円54.3 Mil) to Jun. 2026 (円66.6 Mil).

Susmed Other Current Liabilities Related Terms

Susmed Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Susmed's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Susmed Other Current Liabilities Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Current Liabilities
Get a 7-Day Free Trial 17.21 142.36 254.30 54.29 66.65

Susmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.29 50.23 49.70 55.29 66.65
TSE:4263
55GF Score
Susmed Inc TSE:4263
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Susmed Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円55.3 Mil mean?
Susmed (TSE:4263) has a Other Current Liabilities of 円55.3 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Susmed.
Is Susmed's Other Current Liabilities too high?
Susmed's current Other Current Liabilities is 円55.3 Mil. Overall, Susmed has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Susmed's Other Current Liabilities compare to VEEV and BTSG?
Susmed's Other Current Liabilities of 円55.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Healthcare Providers & Services company?
A good Other Current Liabilities depends on the Healthcare Providers & Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Susmed. Susmed's current Other Current Liabilities is 円55.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Possible Value Trap. The stock's GF Value™ is 円904.00, compared to a current price of 円423.00 — trading 53.2% below its estimated fair value. The current Other Current Liabilities is 円55.3 Mil. Susmed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Susmed (TSE:4263), the current Other Current Liabilities is 円55.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Susmed (TSE:4263) Overvalued in 2026?

Based on GuruFocus' analysis, Susmed stock appears to be undervalued. The current stock price of 円423.00 is trading 53.2% below its estimated GF Value™ of 円904.00. GuruFocus considers Susmed to be Possible Value Trap.

Key valuation signals for TSE:4263:

  • Other Current Liabilities: 円55.3 Mil
  • GF Value™: 円904.00 vs. price of 円423.00 (53.2% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Susmed Business Description

Address 3-7-2 Nihonbashi Honcho, 10th Floor, MFPR Nihonbashi Honcho Building, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
55GF Score

Get the complete analysis for TSE:4263

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円423.00
Price
円904.00
GF Value